1. Home
  2. IBRX vs JXN Comparison

IBRX vs JXN Comparison

Compare IBRX & JXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo ImmunityBio Inc.

IBRX

ImmunityBio Inc.

HOLD

Current Price

$8.46

Market Cap

8.2B

Sector

Health Care

ML Signal

HOLD

Logo Jackson Financial Inc.

JXN

Jackson Financial Inc.

HOLD

Current Price

$131.49

Market Cap

9.0B

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
IBRX
JXN
Founded
2014
1961
Country
United States
United States
Employees
N/A
3890
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Life Insurance
Sector
Health Care
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
8.2B
9.0B
IPO Year
2015
2020

Fundamental Metrics

Financial Performance
Metric
IBRX
JXN
Price
$8.46
$131.49
Analyst Decision
Strong Buy
Hold
Analyst Count
7
5
Target Price
$12.57
$112.40
AVG Volume (30 Days)
8.4M
605.9K
Earning Date
05-08-2026
05-05-2026
Dividend Yield
N/A
3.13%
EPS Growth
38.71
N/A
EPS
N/A
2.98
Revenue
$113,288,000.00
$6,683,000,000.00
Revenue This Year
$88.59
$15.15
Revenue Next Year
$131.15
$3.44
P/E Ratio
N/A
$43.42
Revenue Growth
668.31
104.31
52 Week Low
$1.95
$89.67
52 Week High
$12.43
$140.90

Technical Indicators

Market Signals
Indicator
IBRX
JXN
Relative Strength Index (RSI) 57.26 44.18
Support Level $6.68 $128.97
Resistance Level $8.51 $138.66
Average True Range (ATR) 0.40 4.31
MACD 0.02 -1.17
Stochastic Oscillator 68.10 39.10

Price Performance

Historical Comparison
IBRX
JXN

About IBRX ImmunityBio Inc.

ImmunityBio Inc is a biotechnology company focused on developing and commercializing next-generation immunotherapies designed to activate the patient's immune system and provide durable protection against cancer and infectious diseases. Its approach harnesses both the adaptive and innate immune systems with the Cancer BioShield platform. The platform is built around the proprietary IL-15 superagonist ANKTIVA (nogapendekin alfa inbakicept) and is supported by a portfolio that includes adenovirus-vectored vaccines, NK-cell therapies, and additional immunomodulators. The company operates in the United States and Europe, with the majority of its revenue coming from the United States.

About JXN Jackson Financial Inc.

Jackson Financial Inc helps Americans grow and protect their retirement savings and income to enable them to pursue financial freedom for life. Its retail product offerings are comprised of annuities, designed to help retail investors save for and live in retirement. Its diverse suite of annuities includes a variable, fixed index, and fixed annuities. The company manages its business through three segments: Retail Annuities, Institutional Products, and Closed Life and Annuity Blocks and Corporate and Other segments. The company generates the majority of its revenue from the Retail Annuities segment, which offers a variety of retirement income and savings products of variable annuities, registered index-linked annuities ("RILA"), fixed index annuities, fixed annuities, and payout annuities.

Share on Social Networks: